These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 14976159

  • 1. The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases.
    Singleton A, Myers A, Hardy J.
    Hum Mol Genet; 2004 Apr 01; 13 Spec No 1():R123-6. PubMed ID: 14976159
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of alpha-synuclein in neurodegenerative diseases.
    Bennett MC.
    Pharmacol Ther; 2005 Mar 01; 105(3):311-31. PubMed ID: 15737408
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Conformationally altered proteins cause neurodegenerative diseases].
    Ingelsson M, Nilsson L, Basun H, Aquilonius SM, Lannfelt L.
    Lakartidningen; 2005 Mar 01; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
    [Abstract] [Full Text] [Related]

  • 11. A mitochondrial etiology of neurodegenerative diseases: evidence from Parkinson's disease.
    Khusnutdinova E, Gilyazova I, Ruiz-Pesini E, Derbeneva O, Khusainova R, Khidiyatova I, Magzhanov R, Wallace DC.
    Ann N Y Acad Sci; 2008 Dec 01; 1147():1-20. PubMed ID: 19076426
    [Abstract] [Full Text] [Related]

  • 12. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C, Lee SJ.
    J Neurochem; 2008 Oct 01; 107(2):303-16. PubMed ID: 18691382
    [Abstract] [Full Text] [Related]

  • 13. In search of genes involved in neurodegenerative disorders.
    Pardo LM, van Duijn CM.
    Mutat Res; 2005 Dec 30; 592(1-2):89-101. PubMed ID: 16009383
    [Abstract] [Full Text] [Related]

  • 14. What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?
    Armstrong RA, Lantos PL, Cairns NJ.
    Neuropathology; 2008 Aug 30; 28(4):351-65. PubMed ID: 18433435
    [Abstract] [Full Text] [Related]

  • 15. Alpha-synuclein aggregation in neurodegenerative diseases and its inhibition as a potential therapeutic strategy.
    Paleologou KE, Irvine GB, El-Agnaf OM.
    Biochem Soc Trans; 2005 Nov 30; 33(Pt 5):1106-10. PubMed ID: 16246056
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanisms of neurodegeneration in idiopathic Parkinson's disease.
    Schulz JB.
    Parkinsonism Relat Disord; 2007 Nov 30; 13 Suppl 3():S306-8. PubMed ID: 18267255
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.